| Filed On | Filing |
|---|---|
| 13 Nov 2026 |
Form 4: Shrestha Sanjay K, Director
Received 2,500,000 shares as a grant or award |
| 13 Nov 2026 |
Form 4: Qian LinLin, Director
Received 3,050,000 shares as a grant or award · Received 200,000 shares as a grant or award |
| 13 Nov 2026 |
Form 4: Johnson Tim Donald, Director
Received 3,050,000 shares as a grant or award · Received 200,000 shares as a grant or award |
| 13 Nov 2026 | QUARTERLY REPORT |
| 13 Nov 2026 |
8-K: Regulation FD Disclosure
An AI-Powered Marketplace Platform Helping Small- and Medium-Sized Businesses Access Better Self-Funded Health Plans |
| 13 Nov 2026 |
8-K: Regulation FD Disclosure
Good afternoon, ladies and gentlemen, and welcome to Health In Tech’s Third Quarter 2026 Earnings Conference Call. All participants are currently in listen-only mode. After the prepared remarks, we will open the call for questions. As a ... |
| 13 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Contracted Revenue of $32.7 Million for the First Nine Months of 2026 Pipeline Revenue of $156.4 Million as of October 30, 2026 Distribution Partners Grew 15.9% Year Over Year |
| 12 Nov 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On November 10, 2026, Health In Tech, Inc. (the “Company”) (Nasdaq: HIT) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). For more information on the proposals, which are described below, please refer to the Company’s... |
| 06 Nov 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
As previously disclosed, on August 12, 2026, Health In Tech, Inc. (the “Company”) entered into a Standby Equity Purchase Agreement (the “SEPA”) and a related Registration Rights Agreement. On September 4, 2026, the Company satisfied the ... |
| 05 Nov 2026 |
Form 4: Hasan Zain Syed, Chief Growth Officer
Sold 1,667 shares ($917) |
| 28 Oct 2026 | DEFINITIVE ADDITIONAL MATERIALS |
| 26 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Health In Tech Appoints Sanjay Shrestha as Chief Executive Officer to Lead Next Phase of Growth and Strategic Expansion |
| 22 Oct 2026 |
Form 4: Shrestha Sanjay K, Director
Received 5,000,000 shares as a grant or award · Received 500,000 shares as a grant or award |
| 22 Oct 2026 |
Form 3: Shrestha Sanjay K, Director
Holds 101,200 shares of Class A Common Stock |
| 19 Oct 2026 |
Form 4: Johnson Tim Donald, Director
Gave up 119,728 shares to cover exercise price or tax ($75.4K) |
| 19 Oct 2026 |
Form 4: Hasan Zain Syed, Chief Growth Officer
Gave up 6,756 shares to cover exercise price or tax ($4.26K) · Sold 3,333 shares ($2.07K) |
| 19 Oct 2026 |
Form 4: Qian LinLin, Director
Gave up 47,516 shares to cover exercise price or tax ($29.9K) |
| 19 Oct 2026 | PROSPECTUS |
| 16 Oct 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
On October 14, 2026, Health In Tech, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Nasdaq Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the resignat... |
| 15 Oct 2026 | EFFECT |
Loading...